433 related articles for article (PubMed ID: 25667610)
1. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.
Magri V; Marras E; Restelli A; Wagenlehner FM; Perletti G
Exp Ther Med; 2015 Mar; 9(3):658-666. PubMed ID: 25667610
[TBL] [Abstract][Full Text] [Related]
2. Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
Magri V; Wagenlehner FM; Marras E; VAN Till JW; Houbiers J; Panagopoulos P; Petrikkos GL; Perletti G
Exp Ther Med; 2013 Aug; 6(2):503-508. PubMed ID: 24137216
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary approach to prostatitis.
Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
[TBL] [Abstract][Full Text] [Related]
4. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of influence of the UPOINT-guided multimodal therapy in men with chronic prostatitis/chronic pelvic pain syndrome on dynamic values NIH-CPSI: a prospective, controlled, comparative study.
Krakhotkin DV; Chernylovskyi VA; Bakurov EE; Sperl J
Ther Adv Urol; 2019; 11():1756287219857271. PubMed ID: 31263510
[TBL] [Abstract][Full Text] [Related]
7. Flower Pollen Extract in Association with Vitamins (Deprox 500®) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments.
Macchione N; Bernardini P; Piacentini I; Mangiarotti B; Del Nero A
Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):151-161. PubMed ID: 30488800
[TBL] [Abstract][Full Text] [Related]
8. Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
Sevim M; Alkiş O; Kartal İG; Kazan HO; İvelik Hİ; Aras B; Kabay Ş
Prostate; 2023 Jun; 83(8):751-758. PubMed ID: 36871235
[TBL] [Abstract][Full Text] [Related]
9. Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center.
Zhang Y; Zheng T; Tu X; Chen X; Wang Z; Chen S; Yang Q; Wan Z; Han D; Xiao H; Sun X; Deng C
PLoS One; 2016; 11(4):e0153054. PubMed ID: 27120096
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
Xia D; Wang P; Chen J; Wang S; Jiang H
Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
[TBL] [Abstract][Full Text] [Related]
11. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Magistro G; Wagenlehner FM; Grabe M; Weidner W; Stief CG; Nickel JC
Eur Urol; 2016 Feb; 69(2):286-97. PubMed ID: 26411805
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
[TBL] [Abstract][Full Text] [Related]
14. Sexual dysfunction in type III chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) observed in Turkish patients.
Sönmez NC; Kiremit MC; Güney S; Arisan S; Akça O; Dalkılıç A
Int Urol Nephrol; 2011 Jun; 43(2):309-14. PubMed ID: 20680450
[TBL] [Abstract][Full Text] [Related]
15. Boswellia resin extract and propolis derived polyphenols in patients with type III chronic prostatitis/chronic pelvic pain syndrome: An Italian prospective multicenter study.
Presicce F; Barrese F; Cantiani A; Filianoti A; Tuzzolo D; Di Palma P; Lauretti S; Brunori S; Martini M
Asian J Urol; 2022 Apr; 9(2):139-145. PubMed ID: 35509480
[TBL] [Abstract][Full Text] [Related]
16. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome.
Nickel JC; Downey J; Ardern D; Clark J; Nickel K
J Urol; 2004 Aug; 172(2):551-4. PubMed ID: 15247727
[TBL] [Abstract][Full Text] [Related]
17. Use of the UPOINT phenotype system in treating Chinese patients with chronic prostatitis/chronic pelvic pain syndrome: a prospective study.
Guan X; Zhao C; Ou ZY; Wang L; Zeng F; Qi L; Tang ZY; Dun JG; Liu LF
Asian J Androl; 2015; 17(1):120-3. PubMed ID: 25248659
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal Shockwave Therapy Combined with Drug Therapy in Chronic Pelvic Pain Syndrome : A Randomized Clinical Trial.
Rayegani SM; Razzaghi MR; Raeissadat SA; Allameh F; Eliaspour D; Abedi AR; Javadi A; Rahavian AH
Urol J; 2020 Mar; 17(2):185-191. PubMed ID: 31004340
[TBL] [Abstract][Full Text] [Related]
19. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids.
Maurizi A; De Luca F; Zanghi A; Manzi E; Leonardo C; Guidotti M; Antonaccio FP; Olivieri V; De Dominicis C
Arch Ital Urol Androl; 2019 Jan; 90(4):260-264. PubMed ID: 30655636
[TBL] [Abstract][Full Text] [Related]
20. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS.
Schneider H; Brähler E; Ludwig M; Hochreiter W; Collins MF; Eremenco S; Weidner W
Urology; 2004 Jun; 63(6):1027-30. PubMed ID: 15183940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
